• Feb 26, 2025

Option Care Health (NASDAQ:OPCH) Delivers Impressive Q4, Guides for Strong Full-Year Sales

Alternate site health provider Option Care Health (NASDAQ:OPCH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 19.7% year on year to $1.35 billion. The company’s full-year revenue guidance of $5.4 billion at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $0.44 per share was 21.4% above analysts’ consensus estimates.

  • Feb 26, 2025

Trafigura Says US Policy on Iran Is Oil’s Big Bullish Risk

(Bloomberg) -- Trafigura Group’s head of oil trading Ben Luckock said that US foreign policy towards Iran is the biggest upside risk to crude prices in an otherwise well supplied market.Most Read from BloombergThe Trump Administration Takes Aim at Transportation ResearchNYC’s Congestion Pricing Pulls In $48.6 Million in First MonthShelters Await Billions in Federal Money for Homelessness ProvidersNew York’s Congestion Pricing Plan Faces Another Legal ShowdownNYC to Shut Migrant Center in Former

  • Feb 26, 2025

North Sea Oil Firms Bemoan Continued Uncertainty on Tax, Permits

(Bloomberg) -- Top UK oil and gas producers complained that there’s still little clarity on the government’s plans for taxes and permits for North Sea drilling, making investment decisions difficult. Most Read from BloombergThe Trump Administration Takes Aim at Transportation ResearchNYC’s Congestion Pricing Pulls In $48.6 Million in First MonthShelters Await Billions in Federal Money for Homelessness ProvidersNew York’s Congestion Pricing Plan Faces Another Legal ShowdownNYC to Shut Migrant Cen

  • Feb 26, 2025

Icahn Enterprises (NASDAQ:IEP) Beats Q4 Sales Targets

Holding company and industrial conglomerate Icahn (NYSE:IEP) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 11.1% year on year to $2.37 billion. Its GAAP loss of $0.19 per share was significantly below analysts’ consensus estimates.

  • Feb 26, 2025

Bloomin' Brands (NASDAQ:BLMN) Misses Q4 Sales Targets, Stock Drops

Restaurant company Bloomin’ Brands (NASDAQ:BLMN) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 18.6% year on year to $972 million. Its non-GAAP profit of $0.22 per share was 39.7% below analysts’ consensus estimates.

  • Feb 26, 2025

1 Industrials Stock with Exciting Potential and 2 to Avoid

Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. Still, their generally high capital requirements expose them to the ups and downs of economic cycles, and the market seems confused about where we could go next. This uncertainty has led to a flat return for the industry over the past six months while the S&P 500 was up 6.4%.

  • Feb 26, 2025

Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock Soars

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 10.5% year on year to $391.1 million. On the other hand, the company’s full-year revenue guidance of $1.58 billion at the midpoint came in 2.3% below analysts’ estimates. Its non-GAAP profit of $1.59 per share was 3% above analysts’ consensus estimates.

  • Feb 26, 2025

1 Consumer Stock to Target This Week and 2 to Brush Off

Retailers are overhauling their operations as technology redefines the shopping experience. Still, secular trends are working against their favor as e-commerce continues to take share from brick and mortars. This puts retail stocks in a tough spot, and over the past six months, the industry has pulled back by 3.7%. This performance is a stark contrast from the S&P 500’s 6.4% gain.

  • Feb 26, 2025

Vita Coco (NASDAQ:COCO) Surprises With Q4 Sales But Stock Drops

Coconut water company The Vita Coco Company (NASDAQ:COCO) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 19.9% year on year to $127.3 million. On the other hand, the company’s full-year revenue guidance of $562.5 million at the midpoint came in 1.2% below analysts’ estimates. Its GAAP profit of $0.06 per share was in line with analysts’ consensus estimates.

  • Feb 26, 2025

Bentley (NASDAQ:BSY) Posts Q4 Sales In Line With Estimates, Guides For 9% Growth Next Year

Infrastructure design software provider Bentley Systems (NASDAQ:BSY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 12.6% year on year to $349.8 million. On the other hand, the company’s full-year revenue guidance of $1.48 billion at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $0.21 per share was in line with analysts’ consensus estimates.